Cannabis Studies

The Dutch cannabis coffeeshop model is a better fit for California than trans-national corporate marijuana. Fortunately Prop. 64 was written with those values in mind. Adolescents who smoke pot as early as 14 do worse by 20 on some cognitive tests and drop out of school at a higher ate than non-smokers, confirms the study, […]

by

As several articles have pointed out, it’s generally hard for researchers to study marijuana, since it’s an illegal Schedule 1 substance (despite the fact that medical marijuana is legal in 28 states). But a recently published 395-page report from the National Academies of Sciences, Engineering and Medicine led to a number of conclusions about weed, […]

by

The scope and methodology behind marijuana-related studies is often hindered by the fact that the weed-fearing gatekeepers have made it really difficult for researchers to, you know, research. But a fresh comprehensive study spotted by Esquire offers one of the most detailed looks at weed’s health effects yet, boasting 395 pages of raw research power. […]

by

The Calaveras County Board of Supervisors will review its options for the commercial cannabis industry at a study session scheduled for 9 a.m. on Jan. 31. The current urgency ordinance requires a 4-1 vote for possible extension on Feb. 14. If that vote fails, the bureaucracy built by county staff to register and enforce commercial […]

by

Broadly reports that scientists found a pretty major flaw in the various studies that showed marijuana was linked to increased anxiety, showing that actually the link is pretty weak. Dr. Conal Twomey, a UK-based researcher at the University of Southhampton, found that most studies that showed there was a strong link between weed and anxiety […]

by

Shutterstock Zynerba Pharmaceuticals has two things working in its favor – it uses a synthetic cannabis compound and its phase II study results for its core drug is expected this summer. First off, the benefits of a synthetic cannabis compound. Since Zynerba uses a synthetic version of cannabis, the company doesn’t “touch the plant.” This […]

by

Shutterstock Zynerba Pharmaceuticals has two things working in its favor – it uses a synthetic cannabis compound and its phase II study results for its core drug is expected this summer. First off, the benefits of a synthetic cannabis compound. Since Zynerba uses a synthetic version of cannabis, the company doesn’t “touch the plant.” This […]

by

Shutterstock Zynerba Pharmaceuticals has two things working in its favor – it uses a synthetic cannabis compound and its phase II study results for its core drug is expected this summer. First off, the benefits of a synthetic cannabis compound. Since Zynerba uses a synthetic version of cannabis, the company doesn’t “touch the plant.” This […]

by